Psyence Biomedical Ltd. (PBM)
USD 1.53
(-12.57%)
USD 1.53
(-12.57%)
| Breakdown | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating Cash Flow | -2.94 Million | -519.6 Thousand | -839.17 Thousand |
| Net Income | -51.15 Million | 8.01 Million | 8.23 Million |
| Depreciation & Amortization | 240.00 | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 317.88 Thousand | 221.28 Thousand | 332.06 Thousand |
| Change in working capital | -1.17 Million | -54.43 Thousand | -504.88 Thousand |
| Other non-cash items | 49.27 Million | -8.47 Million | -8.56 Million |
| Investing Cash Flow | -5727.00 | - | -255 Million |
| Investments in PPE | -5727.00 | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | -255 Million |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | -32.03 Thousand |
| Financing Cash Flow | 2.35 Million | 1.17 Million | 256.48 Million |
| Debt repayment | -2.35 Million | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | 256.48 Million |
| Other Financing Activities | - | 1.17 Million | -1.62 Million |
| Accounts receivables | 107.62 Thousand | - | - |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | -1.28 Million | -54.43 Thousand | -504.88 Thousand |
| Cash at beginning of period | 128.67 Thousand | 648.28 Thousand | 4.81 Million |
| Cash at end of period | 762.79 Thousand | 128.67 Thousand | 648.28 Thousand |
| Capital Expenditure | -5727.00 | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 634.12 Thousand | -519.6 Thousand | -4.16 Million |
| Free Cash Flow | -2.95 Million | -519.6 Thousand | -839.17 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.15 Million | -24.76 Thousand | -647.76 Thousand | -62.84 Thousand | 8.01 Million | -24.48 Thousand |
| Depreciation & Amortization | 240.00 | 0.12 | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 317.88 Thousand | 158.94 | - | - | 221.28 Thousand | - |
| Change in working capital | -1.17 Million | -167.18 | 305.59 Thousand | -507.24 Thousand | -54.43 Thousand | 989.18 Thousand |
| Other non-cash items | 49.27 Million | 24.1 Thousand | 90.71 Thousand | 318.66 Thousand | -8.47 Million | -2.28 Million |
| Investing Cash Flow | -5727.00 | -2.86 | 4.21 Million | -247.5 Thousand | - | 242.86 Million |
| Investments in PPE | -5727.00 | -2.86 | -4.00 | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -100.17 Thousand | -247.5 Thousand | - | -247.5 Thousand |
| Sales/Maturities of investments | - | - | 4.31 Million | - | - | 243.11 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.35 Million | 738.34 | -3.88 Million | 492.77 Thousand | 1.17 Million | -242.42 Million |
| Debt repayment | -2.35 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -4.31 Million | - | - | -243.11 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 738.34 | 430 Thousand | 492.77 Thousand | 1.17 Million | 685 Thousand |
| Accounts receivables | 107.62 Thousand | -13.11 | - | - | - | 767.91 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.28 Million | -154.07 | 305.59 Thousand | 260.66 Thousand | -54.43 Thousand | 221.27 Thousand |
| Cash at beginning of period | 128.67 Thousand | - | 9802.00 | 15.95 Thousand | 648.28 Thousand | 128.67 Thousand |
| Cash at end of period | 762.79 Thousand | 73.20 | 88.17 Thousand | 9802.00 | 128.67 Thousand | 15.95 Thousand |
| Capital Expenditure | -5727.00 | -2.86 | -4.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 634.12 Thousand | 73.20 | 78.37 Thousand | -6154.00 | -519.6 Thousand | -112.72 Thousand |
| Free Cash Flow | -2.95 Million | -665.14 | -251.46 Thousand | -251.42 Thousand | -519.6 Thousand | -550.22 Thousand |
SPIC
206560
ROS
ALNY
ESR
603118